Anna Ellsworth

Learn More
BACKGROUND The combination of fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), and vilanterol (VI), a long-acting β2 agonist, is under development as a once-daily treatment of asthma and COPD. The aim of this study was to compare the efficacy of FF/VI with fluticasone propionate (FP)/salmeterol (SAL) in patients with persistent asthma(More)
BACKGROUND Inhaled corticosteroids are a mainstay of therapy for persistent asthma, but suboptimal adherence with twice-daily use is widespread. Fluticasone furoate (FF) is a new inhaled corticosteroid (ICS) suitable for once-daily dosing in asthma. This study was performed to descriptively assess the efficacy and safety of two doses of FF, with no planned(More)
A technique is described for finding the pineal body of the dog. The posterior half of the skull is cut a little behind the parietofrontal suture, through the occipital condyles. The cerebral hemispheres and cerebellum are carefully sliced, disclosing the pineal at the frontal edge of the colliculi. Two types of cells are present, those with completely(More)
  • 1